Furthermore, we have generalized our methodology and applied our investigations to AML, which identified three AML-specific genes (CDC42EP2, CDC42, and ALOX15B) with significant ability to predict AML overall survival, especially for patients with favorable cytogenetic risk and for patients of older chronological age. Here, CDC42 is linked to acute myeloid leukemia.